{
    "Trade/Device Name(s)": [
        "The Ischemia Albumin Cobalt Binding Test",
        "ACB\u00ae Test"
    ],
    "Submitter Information": "Inverness Medical Innovations, Inc.",
    "510(k) Number": "K053196",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023834"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NJV"
    ],
    "Summary Letter Date": "December 16, 2005",
    "Summary Letter Received Date": "November 16, 2005",
    "Submission Date": "November 15, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Ischemia Modified Albumin (IMA)",
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Spectrophotometric detection"
    ],
    "Methodologies": [
        "Cobalt binding capacity measurement",
        "Colorimetric detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for The Ischemia Albumin Cobalt Binding Test (ACB\u00ae), a colorimetric serum assay for IMA detection using spectrophotometry on clinical chemistry analyzers.",
    "Indications for Use Summary": "Quantitative in vitro diagnostic test for detecting ischemia modified albumin in human serum, used with ECG and cardiac troponin for short-term risk stratification in patients with chest pain suggestive of cardiac origin.",
    "fda_folder": "Clinical Chemistry"
}